Laguna Beach, CA, United States of America

Robert M Burk

This inventor holds 166 USPTO granted patents and 30 published patent applications, plus 9 CIPO patents and 20 EPO patents, primarily in Ocular Therapeutics (CPC class C07D-). Top assignees: Allergan, Inc., Allergan Sales, Inc., Azura Ophthalmics Ltd.. Active years: 1994-2023.

USPTO Granted Patents = 166 (Patent Applications = 30)

% Patents Active = 84.9

CIPO Patents = 9 (Patent Applications = 4)

EPO Patents = 20 (Patent Applications = 28)

Average Co-Inventor Count = 2.1

ph-index = 18

Forward Citations = 1,373(Granted Patents)

Forward Citations (Not Self Cited) = 1,154(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Laguna Niguel, CA (US) (2002 - 2007)
Irvine, CA (US) (1994 - 2011)
Laguna Beach, CA (US) (1994 - 2023)

Company Filing History:

Azura Ophthalmics Ltd.

6. 1 out of 834,350

Other

patents

Years Active: 1994-2023

Loading Chart...

Areas of Expertise:

Ocular Disorders

Prostamides

Therapeutic Lactams

Fat Reduction

Prostaglandins

Ester Prodrugs

Glaucoma Treatment

Cyclopentanes

Amides

Compounds

Methods

Therapeutic Agents

166 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11634411 - Compounds and methods for the treatment of ocular disorders (2023-04-25),

2. 11459351 - Compounds and methods for the treatment of ocular disorders (2022-10-04),

3. 11208377 - 3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof (2021-12-28),

4. 10875845 - Compounds and methods for the treatment of ocular disorders (2020-12-29),

5. 10668081 - Prostamide-containing intraocular implant (2020-06-02),

6. 10329284 - Ester prodrugs of gamma-lactams and their use (2019-06-25),

7. 10117877 - Methods for fat reduction (2018-11-06),

8. 9981938 - Quaternary ammonium alkyl esters as stable prodrugs (2018-05-29),

9. 9890118 - Prostamides for the treatment of glaucoma and related diseases (2018-02-13),

10. 9889142 - Prostamide-containing intraocular implant (2018-02-13),

11. 9795615 - Methods for fat reduction (2017-10-24),

12. 9573926 - Amidoalkylenyl and amidoaryl esters, compositions thereof, and methods for their use (2017-02-21),

13. 9540357 - 15-aryl prostaglandins as EP4 agonists, and methods of use thereof (2017-01-10),

14. 9499478 - Substituted cyclopentanes for inducing hair growth (2016-11-22),

15. 9433627 - Prostamides for the treatment of glaucoma and related diseases (2016-09-06),

Title: Inventor Spotlight: Robert M. Burk

Introduction

Meet Robert M. Burk, a prolific inventor based in Laguna Beach, CA, with an impressive portfolio of 166 patents. His groundbreaking work focuses on developing compounds and methods for the treatment of various ocular disorders, revolutionizing the field of ophthalmology.

Latest Patents

Burk's latest patents showcase his innovative approach to addressing ocular surface disorders, such as meibomian gland dysfunction, blepharitis, and dry eye disease. By formulating compositions containing keratolytic conjugates with anti-inflammatory properties, Burk's inventions offer effective therapeutic solutions for patients suffering from these conditions. The topical administration of these compositions to the eyelid margin demonstrates significant therapeutic benefits.

Career Highlights

During his illustrious career, Robert M. Burk has made significant contributions to the field of ophthalmology while working with renowned companies such as Allergan, Inc., and Allergan Sales, Inc. His expertise and dedication have played a pivotal role in advancing the treatment options available for ocular disorders, benefiting countless individuals worldwide.

Collaborations

Burk has had the privilege of collaborating with esteemed colleagues in the industry, including David Frederick Woodward and David W. Old. Together, they have combined their skills and knowledge to create innovative solutions that have had a lasting impact on the field of ophthalmology.

Conclusion

In conclusion, Robert M. Burk's remarkable achievements as an inventor in the field of ophthalmology underscore his commitment to improving the lives of individuals suffering from ocular disorders. His groundbreaking patents and collaborations with industry experts have cemented his legacy as a pioneer in the treatment of ophthalmic conditions.